In reply

Elizabeth C. Powell; Phillip I. Tarr; Stephen B. Freedman

doi:10.1016/j.annemergmed.2021.09.430

In reply

Elizabeth C. Powell, Phillip I. Tarr, Stephen B. Freedman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	88-89
Number of pages	2
Journal	Annals of emergency medicine
Volume	79
Issue number	1
DOIs	https://doi.org/10.1016/j.annemergmed.2021.09.430
State	Published - Jan 2022

Access to Document

10.1016/j.annemergmed.2021.09.430

Cite this

@article{acfd51b9c4ba4d80941b3aba3faeecb7,

title = "In reply",

author = "Powell, {Elizabeth C.} and Tarr, {Phillip I.} and Freedman, {Stephen B.}",

note = "Funding Information: Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org ). The authors have stated that no such relationships exist. The study, (“Oral Ondansetron Administration...”) to which the letter reply is relevant was a subanalysis of data collected as part of 2 large randomized controlled trials. The subanalysis was not funded. The randomized controlled trials were funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Canadian Institutes of Health Research, and Emergency Medical Services for Children Program of the Maternal and Child Health Bureau, Health Resources and Services Administration. ",

year = "2022",

month = jan,

doi = "10.1016/j.annemergmed.2021.09.430",

language = "English",

volume = "79",

pages = "88--89",

journal = "Annals of emergency medicine",

issn = "0196-0644",

number = "1",

}

TY - JOUR

T1 - In reply

AU - Powell, Elizabeth C.

AU - Tarr, Phillip I.

AU - Freedman, Stephen B.

N1 - Funding Information: Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org ). The authors have stated that no such relationships exist. The study, (“Oral Ondansetron Administration...”) to which the letter reply is relevant was a subanalysis of data collected as part of 2 large randomized controlled trials. The subanalysis was not funded. The randomized controlled trials were funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Canadian Institutes of Health Research, and Emergency Medical Services for Children Program of the Maternal and Child Health Bureau, Health Resources and Services Administration.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85121006240&partnerID=8YFLogxK

U2 - 10.1016/j.annemergmed.2021.09.430

DO - 10.1016/j.annemergmed.2021.09.430

M3 - Letter

C2 - 34949415

AN - SCOPUS:85121006240

SN - 0196-0644

VL - 79

SP - 88

EP - 89

JO - Annals of emergency medicine

JF - Annals of emergency medicine

IS - 1

ER -

In reply

Access to Document

Other files and links

Cite this